3M Drug Delivery Expands Operations

3M Drug Delivery Systems has reported the expansion of its capabilities with a new laboratory site at the 3M Singapore facility in Yishun.

Reportedly, the Singapore lab will develop products in both the inhalation and transdermal drug delivery categories, bringing 3M’s innovative inhalers and patches to pharmaceutical customers and patients in the Asia Pacific region.

The company said that the laboratory is the company’s first contract research and development facility in the Asia Pacific region dedicated to pharmaceutical product development.

Commenting on the new lab, the company said that the Singapore facility houses both a feasibility lab and two process development labs.

Jim Vaughan, vice president and general manager at 3M Drug Delivery Systems, said: “Expanding our presence in Singapore will help us provide Asia Pacific customers with a product development service that has both local and global capabilities. Our team in Singapore understands the region’s regulatory requirements, and is able to quickly respond to customer needs. Additionally, our global laboratory network helps us deliver the outstanding quality the 3M brand is known for.”